Oppenheimer & CO Inc Vaccinex, Inc. Transaction History

Oppenheimer & CO Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$1.05 - $1.39 $15,068 - $19,947	-14,351 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$1.04 - $2.12 $18,096 - $36,888	-17,400 Reduced 54.8%	14,351 $15,000
Q3 2021 Nov 12, 2021	SELL	$2.11 - $2.81 $21,522 - $28,662	-10,200 Reduced 24.31%	31,751 $69,000
Q2 2021 Aug 03, 2021	SELL	$2.01 - $3.0 $2,009 - $3,000	-1,000 Reduced 2.33%	41,951 $117,000
Q1 2021 May 10, 2021	SELL	$2.09 - $5.11 $28,841 - $70,518	-13,800 Reduced 24.32%	42,951 $128,000
Q4 2020 Feb 11, 2021	BUY	$1.66 - $2.35 $55,125 - $78,038	33,208 Added 141.05%	56,751 $117,000
Q3 2020 Nov 13, 2020	SELL	$1.75 - $8.19 $20,664 - $96,707	-11,808 Reduced 33.4%	23,543 $42,000
Q2 2020 Aug 11, 2020	BUY	$3.28 - $4.24 $25,256 - $32,648	7,700 Added 27.85%	35,351 $128,000
Q1 2020 May 08, 2020	SELL	$3.96 - $8.37 $6,296 - $13,308	-1,590 Reduced 5.44%	27,651 $111,000
Q4 2019 Feb 07, 2020	BUY	$4.56 - $7.45 $1,554 - $2,540	341 Added 1.18%	29,241 $142,000
Q3 2019 Oct 31, 2019	BUY	$4.02 - $7.93 $52,661 - $103,883	13,100 Added 82.91%	28,900 $207,000
Q2 2019 Aug 09, 2019	BUY	$4.89 - $8.11 $77,262 - $128,137	15,800 New	15,800 $87,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $49.1M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.